Similarly, the three writers, METTL3, METTL16, and ZC3H13 have all been shown to influence PTC progression, tumor size, and prognosis, and as the up- or down-regulation of the enzymes is associated with PTC, they may also be useful as biomarkers of disease. The gene discussed is ZC3H13; the disease is neoplasm.